Results 201 to 210 of about 35,674 (297)

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015-23. [PDF]

Health Aff (Millwood)
Hu JC, Hutchings K, Jalali A, Kapadia SN, Bao Y, Underhill K.   +5 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing.

JAMA Netw Open
Hsu M, Panadero T, Mooney LJ, Kim D, Lawrence D, Yuan A, Siddarth P, Gabrielian S.   +7 more
europepmc   +1 more source

Access to medications for opioid use disorder among primary care patients with homeless experience in the Department of Veterans Affairs. [PDF]

Drug Alcohol Depend
Jones AL, Li H, Baylis JD, Huebler S, Suo Y, Zhang Y, Gelberg L, Zickmund S, Greene TH, Kertesz SG, Gordon AJ.   +10 more
europepmc   +1 more source

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

The Financial Sustainability of Programs to Initiate Medications for Opioid Use Disorder in Emergency Department Settings. [PDF]

Acad Emerg Med
Hodgkin D, Thomas CP, Davis MT, Wicks JJ, Greenfield SF, Meisel ZF, Horgan CM.   +6 more
europepmc   +1 more source

The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Prescription opioid‐related harm remains a significant public health concern. This study aimed to evaluate the efficacy of the Opioid Safety Toolkit, a co‐designed, interactive online resource, in increasing naloxone uptake and healthcare provider discussions among adults prescribed opioids for pain.
Suzanne Nielsen, Frederick Fox, Tina Lam, Alex Waddell, Monica Jung, Bosco Rowland, Jessica Watterson, Dhruv Basur, Chris Prawira, Joshua Paolo Seguin, Patrick Olivier, Jarrod McMaugh, Paul Dietze, Louisa Picco   +13 more
wiley   +1 more source

Three trajectories of implementation of medications for opioid use disorder in primary care. [PDF]

Addict Sci Clin Pract
Kepner W, Vest N, Risner E, Cheng H, Hurley B, Snyder H, McGovern M.   +6 more
europepmc   +1 more source

Patient‐reported outcomes for monitoring substance use treatment: A systematic review of single‐item measures

Addiction, EarlyView.
Abstract Background and aims Measurement‐based care (MBC) is a structured approach using standardized, repeated assessments to monitor treatment progress and guide clinical decision‐making. MBC improves outcomes for substance use treatment but can be time consuming due in part to lengthy assessment tools. Single‐item, patient‐reported outcome measures (
Thomas J. Reese, Hilary A. Tindle, Justin Bachmann, Adam Wright, Jessica S. Ancker, Carolyn M. Audet, Mauli V. Shah, Bryan D. Steitz, Michael H. Levin, Kristopher A. Kast, David Marcovitz, Amanda von Horn, A. Taylor Kelley, John F. P. Bridges   +13 more
wiley   +1 more source

Medicaid prescription cap policies and exemptions for medications for opioid use disorder: A process and content analysis. [PDF]

Health Aff Sch
Hughto JMW, Vento S, Pletta DR, Noh M, Shireman TI, Santostefano CM, Hughes LD, Peterson L, Seymour E, Stettenbauer EG, Dow PM.   +10 more
europepmc   +1 more source